[Malignant blue nevus].
A 35-year-old male patient suffering from a malignant blue naevus is presented. An uncommon melanocytic naevus and malignant melanoma were considered in the differential diagnosis. The final diagnosis was established by histological examination. Immunohistochemical studies showed a strongly positive reaction of the tumour cells for vimentin and S-100 protein. In addition, tumour cells reacted with the antibody HMB-45.
Rupec
R
R
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München.
Eckert
F
F
Ruzicka
T
T
D000328:Adult; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor / Q000032:analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins / Q000032:analysis; D009508:Nevus, Pigmented / Q000473:pathology* / Q000601:surgery; D009418:S100 Proteins / Q000032:analysis; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology* / Q000601:surgery; D014746:Vimentin / Q000032:analysis
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D009418:S100 Proteins; D014746:Vimentin
Maligner blauer Nävus.